共 400 条
[91]
Harris C(2011)Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial Eur Urol 60 742-333
[92]
Harrison SC(2012)Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity J Urol 187 2131-1714
[93]
Kirby M(2015)Summary of European Association of Urology (EAU) guidelines on neuro-urology Eur Urol 69 324-undefined
[94]
Chancellor MB(2008)Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology 70 1707-undefined
[95]
Anderson RU(undefined)undefined undefined undefined undefined-undefined
[96]
Boone TB(undefined)undefined undefined undefined undefined-undefined
[97]
De Ridder D(undefined)undefined undefined undefined undefined-undefined
[98]
Van Der Aa F(undefined)undefined undefined undefined undefined-undefined
[99]
Debruyne J(undefined)undefined undefined undefined undefined-undefined
[100]
D’Hooghe MB(undefined)undefined undefined undefined undefined-undefined